Fasting and stimulated insulin concentrations in four patients with acanthosis nigricans and polycystic ovary syndrome were compared with four patients, matched for weight and ovarian morphology, without acanthosis. The median fasting serum insulin concentrations were 114.2 and 25.1 mU/I in the respective groups (P = 0.02). One additional patient was investigated before and after an 18% increase in weight which resulted in a 170% increase in fasting insulin concentrations and the development of acanthosis nigricans. These observations suggest that there is variation between individuals in the degree of obesity that results in the development of acanthosis and that obese patients with this skin condition represent the severe end of the spectrum of the polycystic ovary syndrome.
Introduction
Acanthosis nigricans, when not related to malignancy, is considered to be a dermal manifestation of hyperinsulinaemia.' The extent to which obesity contributes to insulin resistance in these circumstances is disputed. Several reports have shown that patients with acanthosis nigricans have higher serum insulin concentrations than weight matched subjects without acanthosis, suggesting that their hyperinsulinaemia is not solely caused by obesity.4'5 However, the high levels of circulating insulin associated with acanthosis nigricans have fallen with short term dietary restriction, suggesting that obesity may contribute to the hyperinsulinaemia. 6 The presence of polycystic ovaries, which may also be associated with insulin resistance and acanthosis nigricans,7 has not been carefully identified in previous studies. We describe here a patient whose metabolic status was assessed before and after weight gain and the appearance of acanthosis nigricans. The results from this patient are compared with those from obese patients with and without acanthosis. 
Results
The endocrine results of case EH before and after the appearance of acanthosis nigricans are shown in Table I , together with the median BMI and endocrine profiles from the groups with and without acanthosis. The results from case EH after the emergence of acanthosis follow closely the differences between the patients with and without established acanthosis (Table I ). The group with acanthosis have significantly higher fasting and glucose stimulated serum insulin concentrations and a higher glucose tolerance curve compared with the non-acanthosis group. Figure 1 shows the glucose tolerance curves in patient EH and in the acanthosis and non-acanthosis groups and demonstrates a deterioration in glucose tolerance in association with this skin condition.
The insulin responses in the glucose tolerance tests in patient EH are shown in comparison with the acanthosis and non-acanthosis groups ( Figure  2 Why then is acanthosis rare in the absence of polycystic ovaries? Case EH demonstrates that the appearance of acanthosis is determined by the degree of hyperinsulinaemia. Rarely these high insulin levels are the result of genetic lesions of the insulin pathway.9"-More commonly, obesitymediated insulin resistance contributes to the hyperinsulinaemia. It may be that obesity, which alone does not result in sufficiently high insulin levels to cause acanthosis, has to occur in the presence of another insulin resistant state (the polycystic ovary syndrome) for the skin effect to be manifest.
The metabolic consequences of obesity are demonstrated here by case EH in whom an 18% increase in weight resulted in a 170% increase in the fasting serum insulin concentration and the development of acanthosis nigricans. Obesitymediated insulin resistance can therefore be critical in the aetiology of acanthosis nigricans. There is clearly a variation between individuals in the threshold at which hyperinsulinaemia leads to this skin change and in the degree of insulin resistance achieved for a given weight. Comparisons of weight matched subjects with and without acanthosis nigricans5 simply selects groups with differing insulin sensitivity but provides no information on the cause of the hyperinsulinaemia.
In conclusion, women with acanthosis nigricans and obesity represent the severest form of the polycystic ovary syndrome. The spectrum ranges from lean patients with polycystic ovary syndrome and normal insulin secretion, through lean, mildly hyperinsulinaemic and obese severely hyperinsulinaemic polycystic ovary syndrome to those with acanthosis nigricans. Whereas progression through the severe end of this range may be regulated by obesity, the factors which determine the mild end of the spectrum remain obscure.
